- Home
- KLTO vs ALBT Comparison
KLTO vs ALBT Comparison
Compare KLTO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- ALBT
- Stock Information
- Founded
- KLTO 2019
- ALBT 2014
- Country
- KLTO United States
- ALBT United States
- Employees
- KLTO N/A
- ALBT N/A
- Industry
- KLTO
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KLTO
- ALBT Health Care
- Exchange
- KLTO NYSE
- ALBT Nasdaq
- Market Cap
- KLTO 5.9M
- ALBT 5.7M
- IPO Year
- KLTO N/A
- ALBT N/A
- Fundamental
- Price
- KLTO $1.34
- ALBT $2.57
- Analyst Decision
- KLTO
- ALBT
- Analyst Count
- KLTO 0
- ALBT 0
- Target Price
- KLTO N/A
- ALBT N/A
- AVG Volume (30 Days)
- KLTO 22.5M
- ALBT 104.6K
- Earning Date
- KLTO 08-15-2025
- ALBT 08-18-2025
- Dividend Yield
- KLTO N/A
- ALBT N/A
- EPS Growth
- KLTO N/A
- ALBT N/A
- EPS
- KLTO N/A
- ALBT N/A
- Revenue
- KLTO N/A
- ALBT $807,235.00
- Revenue This Year
- KLTO N/A
- ALBT N/A
- Revenue Next Year
- KLTO N/A
- ALBT N/A
- P/E Ratio
- KLTO N/A
- ALBT N/A
- Revenue Growth
- KLTO N/A
- ALBT N/A
- 52 Week Low
- KLTO $0.11
- ALBT $2.11
- 52 Week High
- KLTO $3.91
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- ALBT 37.26
- Support Level
- KLTO N/A
- ALBT $2.52
- Resistance Level
- KLTO N/A
- ALBT $2.74
- Average True Range (ATR)
- KLTO 0.00
- ALBT 0.28
- MACD
- KLTO 0.00
- ALBT -0.01
- Stochastic Oscillator
- KLTO 0.00
- ALBT 5.15
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.